{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:59:35Z","timestamp":1789390775763,"version":"build-2803163510"},"reference-count":38,"publisher":"Georg Thieme Verlag KG","issue":"07","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2014]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Essential thrombocythaemia (ET) is characterised by enhanced platelet generation and thrombosis. Once daily (od) aspirin incompletely inhibits platelet thromboxane (TX)A2 production in ET. A twice daily (bid) dosing is necessary to fully inhibit TXA2. Whether this dosing regimen affects in vivo prostacyclin (PGI2) biosynthesis is unknown. PGI2 biosynthesis was characterised in 50 ET patients on enteric-coated (EC) aspirin 100 mg od, by measuring its urinary metabolite, 2,3-dinor-6-keto-PGF1\u03b1 (PGI-M). Moreover, in a crossover study 22 patients poorly responsive to standard aspirin based on serum TXB2 levels (&gt;4 ng\/ml) were randomised to different seven-day aspirin regimens: EC aspirin 100 mg od, 100 mg bid, 200 mg od, or plain as-pirin 100 mg od. PGI-M measured 24 hours after the last aspirin intake (EC, 100 mg od) was similar in patients and healthy subjects both on (n=10) and off (n=30) aspirin. PGI-M was unrelated to in vivo TXA2 biosynthesis, and not affected by EC aspirin 100 mg bid or 200 mg od as compared to EC 100 mg od. PGI2 biosynthesis in aspirin-treated ET patients appears unrelated to TXA2 biosynthesis, and not affected by an improved aspirin regimen, demonstrating its vascular safety for future trials.<\/jats:p>","DOI":"10.1160\/th13-10-0844","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T08:13:28Z","timestamp":1395908008000},"page":"118-127","source":"Crossref","is-referenced-by-count":17,"title":["In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia"],"prefix":"10.1160","volume":"112","author":[{"given":"Bianca","family":"Rocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Squellerio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Dragani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Veglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pagliaccia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Porro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia Stella","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tremoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Patrono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Cavalca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2017,12,1]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2012-10-429134","article-title":"Platelet activation and inhibition in polycy-thaemia vera and essential thrombocythaemia","volume":"121","author":"C Patrono","year":"2013","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1056\/NEJMoa035572","article-title":"Efficacy and safety of low-dose aspirin in polycythaemia vera","volume":"350","author":"R Landolfi","year":"2004","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1182\/blood-2010-01-263319","article-title":"Observation versus antiplatelet therapy as primary prophylaxis for thrombosis in low-risk essential thrombocy-thaemia","volume":"116","author":"A Alvarez-Larran","year":"2010","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3324\/haematol.12053","article-title":"Recurrent thrombosis in patients with polycy-thaemia vera and essential thrombocythaemia: incidence, risk factors, and effect of treatments","volume":"93","author":"V De Stefano","year":"2008","journal-title":"Haematologica"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/j.1365-2141.2011.08858.x","article-title":"Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients","volume":"156","author":"F Palandri","year":"2012","journal-title":"Br J Haematol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"C Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood-2009-08-236679","article-title":"The contribution of cyclooxygenase-1 and \u22122 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythaemia: implications for antiplatelet therapy","volume":"115","author":"A Dragani","year":"2010","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1182\/blood-2011-06-359224","article-title":"Aspirin-insensitive thromboxane biosynthesis in essential thrombocythaemia is explained by accelerated renewal of the drug target","volume":"119","author":"S Pascale","year":"2012","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jacc.2008.10.047","article-title":"Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin \u201cresistance\u201d","volume":"53","author":"F Santilli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.thromres.2011.09.017","article-title":"Twice daily aspirin to improve biological aspirin efficacy in patients with essential thrombocythaemia","volume":"129","author":"JG Dillinger","year":"2012","journal-title":"Thromb Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"3377","DOI":"10.1182\/blood-2012-02-406645","article-title":"Overcoming \u201caspirin resistance\u201d in MPN","volume":"119","author":"A Tefferi","year":"2012","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1073\/pnas.96.1.272","article-title":"Systemic biosynthesis of pros-tacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2","volume":"96","author":"BF McAdam","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/0090-6980(76)90047-2","article-title":"Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides","volume":"12","author":"RJ Gryglewski","year":"1976","journal-title":"Prostaglandins"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.1073\/pnas.93.19.10417","article-title":"Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress","volume":"93","author":"JN Topper","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"T Murata","year":"1997","journal-title":"Nature"},{"key":"ref17","first-page":"132ra54.","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"04","author":"Y Yu","year":"2012","journal-title":"Sci Translat Med"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198610163151602","article-title":"Platelet activation in unstable coronary disease","volume":"315","author":"DJ Fitzgerald","year":"1986","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1161\/01.CIR.77.1.142","article-title":"Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction","volume":"77","author":"DJ Fitzgerald","year":"1988","journal-title":"Circulation"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.CIR.71.3.434","article-title":"Endogenous biosynthesis of prostacyc-lin during cardiac catheterisation and angiography in man","volume":"71","author":"L Roy","year":"1985","journal-title":"Circulation"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198404263101701","article-title":"Increased prostacyclin biosynthesis in patients with severe atherosclerosis and platelet activation","volume":"310","author":"GA FitzGerald","year":"1984","journal-title":"N Engl J Med"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0049-3848(88)90267-8","article-title":"Effects of low-dose aspirin on endogenous eicosanoid formation in normal and atherosclerotic men","volume":"50","author":"HR Knapp","year":"1988","journal-title":"Thromb Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1172\/JCI110373","article-title":"Estimated rate of prostacyclin secretion into the circulation of normal man","volume":"68","author":"GA FitzGerald","year":"1981","journal-title":"J Clin Invest"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0140-6736(13)60900-9","article-title":"Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials","volume":"382","author":"Coxib and traditional NSAID Trialists\u2019 (CNT) Collaboration","year":"2013","journal-title":"Lancet"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1136\/bmj.332.7553.1302","article-title":"Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials","volume":"332","author":"PM Kearney","year":"2006","journal-title":"Br Med J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1055\/s-0038-1649916","article-title":"Increased thromboxane biosynthesis in essential thrombocythaemia","volume":"74","author":"B Rocca","year":"1995","journal-title":"Thromb Haemost"},{"key":"ref27","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"SH Swerdlow","year":"2008","edition":"4th ed"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0304-4165(89)90051-2","article-title":"Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man","volume":"992","author":"G Ciabattoni","year":"1989","journal-title":"Biochim Biophys Acta"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"9383","DOI":"10.1073\/pnas.87.23.9383","article-title":"A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalysed mechanism","volume":"87","author":"JD Morrow","year":"1990","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0005-2760(87)90233-5","article-title":"Radioimmunoassay of 11-dehydro-thromboxane B2 in human plasma and urine","volume":"918","author":"G Ciabattoni","year":"1987","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S0022-3565(25)12087-9","article-title":"Immunological characterisation of urinary 8-epi-prostaglandin F2 alpha excretion in man","volume":"275","author":"Z Wang","year":"1995","journal-title":"J Pharmacol Experiment Therapeut"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.prostaglandins.2010.04.002","article-title":"Quantification of urinary PGEm, 6-keto PGF(1alpha) and 2,3-dinor-6-keto PGF(1alpha) by UFLC-MS\/MS before and after exercise","volume":"93","author":"M Blatnik","year":"2010","journal-title":"Prostaglan Lipid Mediators"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1161\/01.CIR.0000124715.27937.78","article-title":"Clinical pharmacology of platelet, monocyte, and vascular cyclooxygenase inhibition by naproxen and low-dose aspirin in healthy subjects","volume":"109","author":"ML Capone","year":"2004","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMra052717","article-title":"Low-dose aspirin for the prevention of atherothrombosis","volume":"353","author":"C Patrono","year":"2005","journal-title":"N Engl J Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.1103333","article-title":"COX-2-derived prostacyclin confers athero-protection on female mice","volume":"306","author":"KM Egan","year":"2004","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e157.","DOI":"10.1371\/journal.pmed.0040157","article-title":"Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?","volume":"04","author":"LA Garcia Rodriguez","year":"2007","journal-title":"PLoS Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.STR.11.1.9","article-title":"Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin","volume":"11","author":"M Ali","year":"1980","journal-title":"Stroke"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1161\/01.STR.0000231683.43347.ec","article-title":"Effect of enteric coating on antiplatelet activity of low-dose aspirin in healthy volunteers","volume":"37","author":"D Cox","year":"2006","journal-title":"Stroke"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCULATIONAHA.112.117283","article-title":"Drug resistance and pseudoresistance: an unintended consequence of enteric coating aspirin","volume":"127","author":"T Grosser","year":"2013","journal-title":"Circulation"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1160\/TH13-10-0844.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T05:19:15Z","timestamp":1746163155000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1160\/TH13-10-0844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":38,"journal-issue":{"issue":"07","published-online":{"date-parts":[[2017,12,1]]},"published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1160\/th13-10-0844","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}